Open-label Clinical Trial of Niraparib Combined With Pembrolizumab for Treatment of Advanced or Metastatic Triple-Negative Breast Cancer

2019417 citationsJournal Articlebronze Open Access

Authors

ClinicalTrials.gov identifier: NCT02657889.

Good health and well-being

Published in: JAMA Oncology

Volume 5, Issue 8, pp. 1132-1132

Field-Weighted Citation Impact: 21.49